Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04641871
Title Sym021 in Combination With Either Sym022 or Sym023 in Patients With Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Symphogen A/S
Indications

transitional cell carcinoma

lung small cell carcinoma

endometrial cancer

cholangiocarcinoma

Therapies

Sym021 + Sym023

Sym021 + Sym022

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN


No variant requirements are available.